Living Donor Liver Transplantation with Small Left Lobe Grafts: Prospective Validation of Utility of Splenectomy in Selected Recipients

14 January 2025 : Original article

Hajime Matsushima^{ABCDEF 1*}, Akihiko Soyama

^{BCD 1}, Takanobu Hara

^{BCD 1}, Takashi Hamada

^{BCD 1}, Yuta Kawaguchi^{BCD 1}, Kazushige Migita^{BCD 1}, Ayaka Satoh^{BCD 1}, Yamashita Mampei

^{BCD 1}, Hajime Imamura

^{BCD 1}, Ayaka Kinoshita^{BCD 1}, Tomohiko Adachi^{BCD 1}, Susumu Eguchi^{BCD 1}

DOI: 10.12659/AOT.946374

Ann Transplant 2025; 30:e946374

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Summary of patients who received living donor liver transplantation with left lobe grafts in era 3.

	Previous policy			Current policy	P*
	Era 1 (n=41)	Era 2 (n=17)	Total (n=58)	Era 3 (n=8)
	1.2005–12.2014	1.2015–3.2021	1.2005–3.2021	4.2021–1.2024
Splenectomy	21 (51.2%)	6 (35.3%)	27 (46.6%)	6 (75.0%)	0.258
Early allograft dysfunction	30 (73.2%)	5 (29.4%)	2 (60.3%)	2 (25.0%)	0.125
Small-for-size syndrome	24 (58.5%)	8 (47.1%)	32 (55.2%)	2 (25.0%)	0.143
^* Previous policy vs current policy.

Back to the Article